Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Regional opening strategies with commuter testing and containment of new SARS-CoV-2 variants

View ORCID ProfileMartin J. Kühn, Daniel Abele, View ORCID ProfileSebastian Binder, Kathrin Rack, Margrit Klitz, Jan Kleinert, Jonas Gilg, Luca Spataro, Wadim Koslow, View ORCID ProfileMartin Siggel, View ORCID ProfileMichael Meyer-Hermann, Achim Basermann
doi: https://doi.org/10.1101/2021.04.23.21255995
Martin J. Kühn
1Institute for Software Technology, German Aerospace Center, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martin J. Kühn
  • For correspondence: Martin.Kuehn@DLR.de SB@Theoretical-Biology.de MMH@Theoretical-Biology.de Achim.Basermann@DLR.de
Daniel Abele
1Institute for Software Technology, German Aerospace Center, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastian Binder
2Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sebastian Binder
  • For correspondence: Martin.Kuehn@DLR.de SB@Theoretical-Biology.de MMH@Theoretical-Biology.de Achim.Basermann@DLR.de
Kathrin Rack
1Institute for Software Technology, German Aerospace Center, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margrit Klitz
1Institute for Software Technology, German Aerospace Center, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Kleinert
1Institute for Software Technology, German Aerospace Center, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonas Gilg
1Institute for Software Technology, German Aerospace Center, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luca Spataro
1Institute for Software Technology, German Aerospace Center, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wadim Koslow
1Institute for Software Technology, German Aerospace Center, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Siggel
1Institute for Software Technology, German Aerospace Center, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martin Siggel
Michael Meyer-Hermann
2Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael Meyer-Hermann
  • For correspondence: Martin.Kuehn@DLR.de SB@Theoretical-Biology.de MMH@Theoretical-Biology.de Achim.Basermann@DLR.de
Achim Basermann
1Institute for Software Technology, German Aerospace Center, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Martin.Kuehn@DLR.de SB@Theoretical-Biology.de MMH@Theoretical-Biology.de Achim.Basermann@DLR.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Despite the accelerating vaccination process, a large majority of the population is still susceptible to SARS-CoV-2. In addition, we face the spread of novel variants. Until we overcome the pandemic, reasonable mitigation and opening strategies are crucial to balance public health and economic interests.

Methods We model the spread of SARS-CoV-2 over the German counties by a graph-SIR-type model with particular focus on commuter testing. We account for political interventions by varying contact reduction values in private and public locations such as homes, schools, workplaces, and other. We consider different levels of lockdown strictness, commuter testing strategies, or the delay of intervention implementation. We conduct numerical simulations to assess the effectiveness of the different intervention strategies after one month. The virus dynamics in the counties are initialized randomly with incidences between 75-150 weekly new cases per 100,000 inhabitants (red zones) or below 10 (green zones) and consider 25 different initial scenarios of randomly distributed red zones (between 2 and 20 % of all counties). To account for uncertainty, we consider an ensemble set of 500 Monte Carlo runs for each scenario.

Results We find that the strength of the lockdown in regions with out of control virus dynamics is most important to avoid the spread into neighboring regions. With very strict lockdowns in red zones, commuter testing rates of twice a week can substantially contribute to the safety of adjacent regions. In contrast, less strict lockdowns with the same commuter testing rate quickly and substantially lead to overall higher infection dynamics. A further key contributor is the potential delay of the intervention implementation. In order to keep the spread of the virus under control, strict regional lockdowns with minimum delay and commuter testing of at least twice a week are advisable.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101003480 and by the Initiative and Networking Fund of the Helmholtz Association. It was supported by German Federal Ministry of Education and Research for the project CoViDec (FKZ: 01KI20102). The funding bodies had no role in the design of the study, collection, analysis, and interpretation of the results, or writing the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Not applicable.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The parameters to setup the simulations are provided in the current article and [11]. The simulation output for all different strategies, scenarios and Monte Carlo runs presented here make up more than 100 GB in over 1.9 million items and cannot be shared easily. Particular results can be shared upon request. Intra- and intercounty contact and raw, non-normalized mobility data for initialization are provided in text files.

  • Abbreviations

  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted April 26, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Regional opening strategies with commuter testing and containment of new SARS-CoV-2 variants
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Regional opening strategies with commuter testing and containment of new SARS-CoV-2 variants
    Martin J. Kühn, Daniel Abele, Sebastian Binder, Kathrin Rack, Margrit Klitz, Jan Kleinert, Jonas Gilg, Luca Spataro, Wadim Koslow, Martin Siggel, Michael Meyer-Hermann, Achim Basermann
    medRxiv 2021.04.23.21255995; doi: https://doi.org/10.1101/2021.04.23.21255995
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Regional opening strategies with commuter testing and containment of new SARS-CoV-2 variants
    Martin J. Kühn, Daniel Abele, Sebastian Binder, Kathrin Rack, Margrit Klitz, Jan Kleinert, Jonas Gilg, Luca Spataro, Wadim Koslow, Martin Siggel, Michael Meyer-Hermann, Achim Basermann
    medRxiv 2021.04.23.21255995; doi: https://doi.org/10.1101/2021.04.23.21255995

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (161)
    • Allergy and Immunology (416)
    • Anesthesia (91)
    • Cardiovascular Medicine (860)
    • Dentistry and Oral Medicine (159)
    • Dermatology (97)
    • Emergency Medicine (250)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
    • Epidemiology (8562)
    • Forensic Medicine (4)
    • Gastroenterology (384)
    • Genetic and Genomic Medicine (1753)
    • Geriatric Medicine (167)
    • Health Economics (373)
    • Health Informatics (1244)
    • Health Policy (621)
    • Health Systems and Quality Improvement (468)
    • Hematology (196)
    • HIV/AIDS (374)
    • Infectious Diseases (except HIV/AIDS) (10303)
    • Intensive Care and Critical Care Medicine (553)
    • Medical Education (192)
    • Medical Ethics (51)
    • Nephrology (212)
    • Neurology (1678)
    • Nursing (97)
    • Nutrition (251)
    • Obstetrics and Gynecology (326)
    • Occupational and Environmental Health (451)
    • Oncology (929)
    • Ophthalmology (263)
    • Orthopedics (102)
    • Otolaryngology (172)
    • Pain Medicine (114)
    • Palliative Medicine (40)
    • Pathology (253)
    • Pediatrics (536)
    • Pharmacology and Therapeutics (253)
    • Primary Care Research (208)
    • Psychiatry and Clinical Psychology (1770)
    • Public and Global Health (3841)
    • Radiology and Imaging (624)
    • Rehabilitation Medicine and Physical Therapy (320)
    • Respiratory Medicine (520)
    • Rheumatology (208)
    • Sexual and Reproductive Health (168)
    • Sports Medicine (158)
    • Surgery (190)
    • Toxicology (36)
    • Transplantation (101)
    • Urology (76)